Outcomes for Oligometastatic Head and Neck Cancer Undergoing SBRT: Results From an International Multi-Institutional Consortium

Treatment of oligometastatic disease with SBRT has shown the potential to improve disease control and survival in trials largely focused on lung and prostate cancer. Outcomes in other sites, such as head and neck cancers (HNC) are poorly defined. Here we report the results of a multi-institutional cohort of oligometastatic HNC patients receiving SBRT.Data on HNC patients treated between 2008 and 2016 was extracted from an international...